BC

Birchview Capital Portfolio holdings

AUM $132M
1-Year Est. Return 53.17%
This Quarter Est. Return
1 Year Est. Return
+53.17%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$132M
AUM Growth
+$31.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
79
New
Increased
Reduced
Closed

Top Buys

1
+$6.51M
2
+$3.06M
3
+$1.77M
4
BCYC
Bicycle Therapeutics
BCYC
+$1.19M
5
GPCR icon
Structure Therapeutics
GPCR
+$1.18M

Top Sells

1
+$1.43M
2
+$1.17M
3
+$964K
4
AXGN icon
Axogen
AXGN
+$748K
5
XNCR icon
Xencor
XNCR
+$550K

Sector Composition

1 Healthcare 76.79%
2 Technology 17.82%
3 Energy 4.7%
4 Materials 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBIO icon
51
BridgeBio Pharma
BBIO
$14.7B
$451K 0.34%
8,688
+3,688
AVTX icon
52
Avalo Therapeutics
AVTX
$279M
$394K 0.3%
+31,000
GH icon
53
Guardant Health
GH
$14.6B
$375K 0.28%
+6,000
PHVS icon
54
Pharvaris
PHVS
$1.63B
$370K 0.28%
+14,847
ZBIO
55
Zenas BioPharma
ZBIO
$1.08B
$366K 0.28%
16,500
GOSS icon
56
Gossamer Bio
GOSS
$583M
$363K 0.27%
138,176
APLS icon
57
Apellis Pharmaceuticals
APLS
$2.52B
$317K 0.24%
14,000
VTYX icon
58
Ventyx Biosciences
VTYX
$997M
$307K 0.23%
98,827
+70,027
CADL icon
59
Candel Therapeutics
CADL
$351M
$306K 0.23%
60,000
KIDS icon
60
OrthoPediatrics
KIDS
$460M
$296K 0.22%
16,000
-10,000
TELA icon
61
TELA Bio
TELA
$45.4M
$231K 0.17%
155,000
NKTR icon
62
Nektar Therapeutics
NKTR
$766M
$229K 0.17%
+4,021
XLV icon
63
State Street Health Care Select Sector SPDR ETF
XLV
$41B
$208K 0.16%
+1,498
KPTI icon
64
Karyopharm Therapeutics
KPTI
$116M
$183K 0.14%
27,985
APLT icon
65
Applied Therapeutics
APLT
$14.5M
$136K 0.1%
225,000
-55,000
CGEM icon
66
Cullinan Oncology
CGEM
$633M
$119K 0.09%
20,000
IFRX icon
67
InflaRx
IFRX
$67.7M
$67K 0.05%
50,000
ALMS
68
Alumis Inc
ALMS
$2.98B
$39.9K 0.03%
10,000
ZNTL icon
69
Zentalis Pharmaceuticals
ZNTL
$192M
$25.7K 0.02%
17,000
APVO icon
70
Aptevo Therapeutics
APVO
$9.42M
– –
-556
AXDX
71
DELISTED
Accelerate Diagnostics
AXDX
– –
-325,239
BCRX icon
72
BioCryst Pharmaceuticals
BCRX
$1.4B
– –
-40,000
BPMC
73
DELISTED
Blueprint Medicines
BPMC
– –
-2,700
COGT icon
74
Cogent Biosciences
COGT
$5.98B
– –
-40,000
MLTX icon
75
MoonLake Immunotherapeutics
MLTX
$1.19B
– –
-8,000
1 2
3
4